drugset / Trial / NCT01808144
Lesinurad and Febuxostat Combination Extension Study in Gout
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will assess the serum uric acid lowering effects and safety of lesinurad in combination with febuxostat over a long-term timeframe.
Timeline
- Start
- 2013-03-01
- Primary completion
- 2016-08-09
- Completion
- 2016-10-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Febuxostat | Small molecule | 80 mg | — |
| Subject | Lesinurad | Small molecule | 200 mg | — |
| Subject | Lesinurad | Small molecule | 400 mg | — |